Completed PHASE1 INTERVENTIONAL NCT00004258

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer

Sponsor: Indiana University School of Medicine

Conditions Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous/Nonmalignant Condition Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific

Interventions cilengitide

Updated 6 times since 2017 Last updated: Sep 16, 2014 Started: Dec 31, 1999 Primary completion: Aug 31, 2001 Completion: Sep 30, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Chronic Myeloproliferative Disorders and Leukemia, this trial is completed. The trial is conducted by Indiana University School of Medicine and has accumulated 6 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Dec 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indiana University School of Medicine
National Cancer Institute (NCI)

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States